A method of preventing gait abnormalities in a patient with Parkinson's disease or of improving or restoring to normal the gait of a patient with Parkinson's disease, comprising the step of administering to said patient an amount of one or more hepatocyte growth factor mimics sufficient to prevent, improve or restore to normal said gait, said one or more hepatocyte growth factor mimics having a general structural formula 1 2 3 where Ri is one of an N-acyl group, a substituted or unsubstituted phenyl, a norleucine group, and an amino acid selected from tyrosine, phenylalanine, aspartic acid, arginine, isoleucine, serine, histidine, glycine, cysteine, methionine, tryptophan, lysine norvaline, ornithine, and s-benzyl cysteine
The benzyl alcohol preservative extends peptide stability
It is important not to stop or delay evidence-based DMARD or biologic therapy in favour of experimental GLP-1 therapy outside a clinical trial
Glutathione is often called the master antioxidant, and for good reason
Morning dosing also pairs neatly with Vitamin C, since many people already have a Vitamin C-rich breakfast (citrus, amla, guava) or supplement alongside it, supporting the antioxidant recycling covered later in this guide
Godman H